BACKGROUND AND AIM
This review was undertaken with an eye of providing an evidence-based guide for internists in the utilization of the various techniques in the diagnosis of pulmonary emboli. Pulmonary angiography represents a group of tests that are used alone or in combination to evaluate for the presence of pulmonary emboli (PE) † and encompasses computed tomography (CT) pulmonary angiography (which is noninvasive), catheter digital subtraction angiography (DSA) (which requires a right heart catheterization), as well as magnetic resonance imaging (MRI) angiography. All forms of angiography require the use of intravenous contrast. CT pulmonary angiography and, to a lesser extent, conventional DSA (as it has to be performed by an interventional radiologist) are available emergently in almost all centers. Magnetic resonance imaging (MRI) angiography currently is limited to the clinical research setting and is limited by the cost and time it takes to perform a study.
INDICATIONS FOR PULMONARY ANGIOGRAPHY
• CT and invasive DSA are used in the investigation of suspected pulmonary embolism.
• CT angiography is now performed as a first line test to evaluate clinically suspected pulmonary embolism [1] . Negative CT angiography studies allow anticoagulation to be safely withheld [2, 3] , and CT angiography provides a definitive diagnosis in the majority of cases [4] [5] [6] .
• DSA (catheter angiography) remains the gold-standard test providing an unchallenged diagnosis in 96 percent of cases [7] , which when negative, can be used to withhold anticoagulation [8] .
• Pulmonary angiography is used to further investigate inconclusive pulmonary embolism testing performed by other modalities; e.g., intermediate or low probability V:Q scan in the correct clinical setting or an unexplained positive D-Dimer test.
SELECTING PATIENTS AT HIGHER RISK AND POORER PROGNOSIS
A subset of patients with pulmonary embolism present with circulatory collapse (shock) and refractory hypoxemia require an emergent definitive diagnosis in order to initiate potentially life-saving therapies.
The Management Strategies and Determinants of Outcome in Acute Pulmonary Embolism Trial (MAPPET) reviewed 1,001 patients at 204 centers and found an in-hospital mortality rate of 31 percent in patients with hemodynamic instability [9] . A prospective, 296 patient, singleinstitution study [10] , showed that those patients who did not have cancer, heart failure, previous deep vein thrombosis (DVT), systolic blood pressure < 100 mmHg, arterial PaO 2 < 8 kPa, or the presence of deep-vein thrombosis on ultrasound were less likely to have recurrent thromboembolic event, major bleeding, or die at three months. 
INCREASING THE PRETEST PROBABILITY OF A POSITIVE TEST
• EKG signs: tachycardia, recent surgery, previous thromboembolic event, older age, band atelectasis, or elevation of a hemi diaphragm on chest x-ray (CXR) film, right bundle branch block (RBBB), S1Q3T3, or non-specific T wave changes [15, 16] .
• Increased alveolar-arterial gradient on room air blood gas. In one study, a room air blood gas that is not elevated (alveolar arterial blood gas gradient < 
CONTRA-INDICATIONS TO PULMONARY ANGIOGRAPHY (CATHETER OR CT)
All contra-indications to invasive and non-invasive angiography are relative [23, 24] , and there are specific therapies that can be applied to reduce the risk of adverse events in high-risk patients [25] . High-risk patients should be well hydrated and administered non-ionic, iso-osmolar contrast material at a minimal dose [23, 26, 27] . In a prospective survey of 109,546 patients stratified into high-risk and lowrisk groups receiving ionic and non-ionic contrast media, respectively, it was concluded that fewer adverse drug reactions were noted in high-risk patients receiving non-ionic contrast than in those low-risk patients receiving ionic contrast [28] .
Patients at high-risk groups for adverse reactions to radiographic contrast administration include those with:
• Prior contrast reactions. The most important risk factor for an allergic contrast reaction is a prior contrast reaction [29] .
• Abnormal renal function (elevated creatinine). All patients with impaired renal function should be considered high risk. Risk increases with decreasing renal function and volume of contrast injected [30] [31] [32] [33] [34] . Contrast side-effects (nephropathy and hypersensitivity) are reduced with the use of non-ionic contrast [28] . Nephrotoxic drugs such as aminoglycosides and non-steroidal anti-inflammatory increase the risk of post contrast renal dysfunction [23] .
Patients with multiple myeloma [35] or diabetes without renal dysfunction are not at higher risk for nephrotoxicity [36] . Acetylcysteine may be of benefit in minimizing contrast induced renal impairment in patients with preexisting renal dysfunction [37] .
• Abnormal cardiac function.
• Significant allergies. Shell fish and seafood allergies are no more significant in predicting adverse contrast reaction than any other allergy [30, 38] . Pretreatment with steroids for significant allergies is warranted [24, 39] .
• Asthma. Even well-controlled asthma is a risk factor for contrast reaction [30] .
Patients with significant reactive airway disease can be pretreated with steroids [24, 39] .
• Patients receiving contrast with preexisting conditions including cardiac disease may aggravate pre-existing arrhythmias, precipitate angina or congestive heart failure; pheochromocytomas may lapse into hypertensive crises; myasthenia gravis may experience acute worsening of respiratory symptoms of myasthenia; uncontrolled hyperthyroidism may enter a thyroid storm; sickle cell patients can experience sickle cell crisis; and those with paroxysmal nocturnal hemoglobinuria may experience worsening of symptoms [23, 34] . Patients with pheochromocytoma should be pretreated with a beta blocker prior to contrast administration [23] .
• Patients treated with nephrotoxic drugs, interleukin-2, or metformin. Cancer patients on interleukin-2 experience predominantly systemic reactions and are treated symptomatically [40] [41] [42] .
As Metformin may induce lactic aci-dosis [43] [44] [45] , patients with type II diabetes on metformin should have their metformin stopped 48 hours in advance of the scan and should not resume metformin before 48 hours after contrast administration and until renal function has been checked [46] • Pregnancy is a relative contra-indication to CT angiography and is safer than V:Q scanning. The relative radiation dose to a fetus is less with CT angiography than with V:Q scanning if scanning is not extended caudal to 5 mm inferior to the xiphoid process [48] . The safety of contrast agents has not been proven in pregnancy or lactation.
• For catheter angiography, left bundle branch block (LBBB) and increased right ventricular end diastolic pressure also increase the risk of complications.
TREATMENT OF COMPLICATIONS
• Treatment of intra-or post-procedure adverse contrast reactions is symptomatic [23] . Adverse drug reactions occur in 3.8 to 12.66 percent (0.09 to 0.22 percent severe) with ionic contrast and 1.2 to 3.13 percent (0.02 to 0.04 percent severe) with non-ionic contrast [28, 38] . Extravasation of contrast media into soft tissues surrounding a vein during an injection can lead to tissue damage from direct toxicity of the contrast agent or from pressure effects, such as a compartment syndrome. No specific treatment has been shown unequivocally to be effective, so most extravasation injuries are treated conservatively with supportive measures [46] . • Specifically in those at high risk, pretreatment with steroids may help reduce the risk of hypersensitivity [32, 47, 49] . Pre-treatment of pheochromocytoma patients with beta blocker is essential [23] . The incidence of renal toxicity and further deterioration in those with preexisting renal failure may be reduced by the use of pre-procedure isotonic hydration or the use of non-ionic iso-osmolar contrast agents [27, 36, 50, 51] . No other drugs (e.g., diuretics, calcium channel blockers) have been shown to reduce the incidence of renal toxicity either prior to or post administration of contrast [53] .
• For patients with allergies or prior contrast reaction, methylprednisone at 32 mg at 12 and 2 hours prior to the contrast study with or without 50 mg diphenhydramine one hour before the study has been recommended [39, 46] . • In a large study of 1,350 catheter angiograms with ionic contrast material, right ventricular end diastolic pressure over 20 mm Hg was associated with a slightly higher mortality [52] . In addition, this study also showed 17 myocardial conduction complications with six deaths and 20 direct cardiac traumas due to catheter manipulation. A study performed 15 years later of 547 patients with non-ionic contrast and modern (curved/pigtail) catheters showed no effect of pulmonary artery pressure on mortality or complications, no cardiac perforations, and two myocardial conduction complications with no deaths [54] . Minor bruising and pain may occur at the site of puncture. The EKG strip should be monitored by a dedicated person during the procedure as LBBB can progress to RBBB with catheter manipulation in the right ventricle. To minimize the risk of complications, patients should have selective catheterization of the pulmonary arteries with low-contrast volume and non-ionic contrast.
CONSIDERATIONS IN CHOOSING CATHETER ANGIOGRAPHY
• Catheter angiography is accurate (96 percent give unchallenged diagnosis) and carries a low-risk profile (0.9 to 1.5 percent major and 4.8 to 5 percent minor complication rate), which is lower than empiric anticoagulation [2, 7, [54] [55] [56] [57] [58] .
• If an angiogram is negative, anticoagulation may be safely withheld [8] .
• Patients with right ventricular end diastolic pressure over 20 mm Hg and pulmonary artery pressure of over 70 mm HG are associated with greater mortality [52] . Consider unilateral pulmonary angiography in patients with severe pulmonary hypertension if catheter angiography is deemed imperative.
• Patients with a LBBB should have a transvenous pacing lead placed in the event of complete heart block.
• Catheter angiography is weaker in the detection of small peripheral emboli as compared with large central emboli (yet it is still better than CT angiography) [55, 59] .
CONSIDERATIONS IN CHOOSING CT ANGIOGRAPHY
CT angiography is readily available, does not require an interventional radiologist, and offers the best chance of a diagnosis of the non-invasive tests. CT angiography is definitive, providing high sensitivity and specificity (Table 1) . Two metaanalyses of CT angiography of 1,250 patients [60] and 1,171 patients [61] showed a sensitivity of 74 percent, and 88 percent specificity of 90 percent and 92 percent, respectively, for the detection of PE. Up to 53 percent of patients can have a definitive diagnosis other than PE confirmed with CT, and 88 percent of patients without PE can have other findings of clinical significance [2, [4] [5] [6] .
• CT angiography can be performed on all standard spiral CT scanners and is therefore available virtually at all hours at all hospitals. CT angiography may be effectively interpreted by trainees in excluding life-threatening emboli [62] . CT angiography has replaced V:Q scanning as the first-line study in practice guidelines outside the United States [63] . • The radiation dose from CT angiography is lower than invasive angiography and, with thin collimation and high pitch, is equivalent to the background radiation a person receives from the environment in one year [64, 65] . CT angiography is safer to a fetus than V:Q scanning. V:Q scanning carries a higher radiation dose to the fetus than CT angiography [48] .
• CT angiography has a higher likelihood of a definitive diagnosis than V:Q scanning. A recent meta-analysis of more than 7,000 patients noted that a combination of V:Q scanning with clinical correlation and D-dimer results could be very effective to exclude PE. However, the study noted that CT scanning alone may be as effective [66] . Prior studies on CT angiography were misleading in that they included data from before the advent of spiral CT scanning and, therefore, gave a false sense of superiority of V:Q scanning [67] .
• CT can also show findings that may mimic symptoms of PE such as atelectasis, pleural effusions, pneumonia, nodules, and masses.
• Well-tested clinical models exist to improve the usefulness of the poor sensitivity specificity of V:Q scanning. CT angiography may be used effectively to evaluate an intermediate probability V:Q scan [68] .
• CT angiography has a three-month negative predictive value of 95 to 100 percent [3, 6, 68, 70] and is similar to the negative predictive value of a normal or very low probability V:Q scan [3, 69] , while a positive CT angiogram has similar positive predicative value to V:Q scanning [61].
• If a CT is negative for PE, there is no need for further imaging or anticoagulation [2, 3, 6, 58, 69] .
• Physicians who are trained as chest radiologists have a better ROC curve than general radiologists who are in turn better than non-radiologists [71, 72] . Ergo, experienced radiologists are better at detecting pulmonary emboli than those with relatively less experience [72] . However, residents are capable of providing preliminary interpretations that will detect lifethreatening pulmonary emboli [62] .
• CT pulmonary angiography is weaker than catheter angiography at detecting peripheral, smaller emboli [7, 59, 69, 73, 74] .
ALTERNATIVES TO PULMONARY ANGIOGRAPHY
There are no absolute contraindications to CT or invasive angiography.
Nevertheless, if any relative contraindications exist, another technique may be attempted as a first-line investigation as long as the patient is not hemodynamically unstable. [23, 60, [75] [76] [77] 91] . In hemodynamically stable patients, other techniques in combination (V:Q scanning with DDimer results and clinical suspicion) can yield acceptable results (under 3 percent failure rate) in the diagnosis of PE [66] .
ELISA D-dimer or high sensitivity second generation latex agglutination Ddimer: A meta-analysis of 11 prior Ddimer trials shows that a negative ELISA D-Dimer has 94 percent sensitivity for excluding pulmonary embolism. A positive result has a poor specificity of only 45 percent [18] . Sensitivity of first generation non ELISA D-Dimer testing (latex agglutination) is only 70 percent [7] .
V:Q scanning can be used as an alternative test if CT pulmonary angiography is deferred. According to the Prospective Investigation of Pulmonary Embolism Diagnosis study (PIOPED), patients with a high clinical suspicion may have an embolus despite a low probability test. Furthermore, V:Q scanning may not provide a definitive diagnosis in up to 75 percent of patients [55] . When V:Q scanning is positive in the appropriate clinical setting, it has high sensitivity and when negative in the appropriate clinical setting has high specificity [55] , and its efficacy may be increased if clinical models are used where V:Q scanning is used in combination with D-dimers and clinical suspicion [66] . Additional testing, however, is frequently required to achieve a diagnosis (PIER module on ventilation-perfusion scintigraphy) and therefore V:Q scans have been mostly replaced by CT angiography as a first-line investigation [63, 75, 79] . V:Q scanning is not as readily available after hours as CT angiography and takes considerably longer, and there is a higher fetal radiation dose in pregnant patients [48] .
Evaluation of the lower extremity venous system is used as an adjunct in the diagnosis of deep-vein thrombosis that may co-exist with PE. Sensitivity is over 90 percent for venous thrombosis in lower extremity [80] [81] [82] , but this may not be useful in non-occlusive thrombosis [83] , and a single negative lower extremity ultrasound does not exclude pulmonary emboli [84] . It is of note that only 30 to 50 percent of patients with PE have a positive leg ultrasound [85, 86] and that 25 percent of patients with intermediate probability lung scans and serial negative Doppler scans have PE. Lower extremity ultrasound does not add any additional details when CT pulmonary angiography is performed [6, 61] . Between 8 to 18 percent of patients without PE may have deep venous thrombosis demonstrated by CT venography [87, 88] . CT venography has a sensitivity of 94.3 percent and specificity of 92.1 percent for the detection of deep venous thrombosis [88] . CT venography has not yet entered routine use as it carries a relatively high dose especially to the gonads [64, 88] and there is no method of stratifying before scanning which patients will require the additional CT venography evaluation. Furthermore, the absence of thrombosis in the lower extremity does not exclude PE [84] . Therefore, ultrasound continues to play a primary role in the evaluation of the lower extremity venous system.
TECHNICAL DETAILS: CT ANGIOGRAPHY
• CT pulmonary angiograms must be performed on spiral CT scanners with automated synchronization between scan commencement and injection of intravenous iodinated contrast. The use of newer, faster, multi-slice spiral scanners may reduce contrast load [83] . Spiral (spiral = helical) CT scanners include single-slice and multislice scanners but not axial scanners.
• A chest CT with contrast is not equivalent to CT pulmonary angiography.
• Older axial CT scanners cannot perform CT pulmonary angiography even though they can produce adequate chest CT.
• Contrast must be delivered with a mechanical injector via a peripheral or central intravenous line at a minimum of 2 ml/sec for a total volume of 120 to 140 ml. It is acceptable to use an empiric delay between the initiation of contrast injection and scanning of 20 sec. A contrast timing test-run (that may be automated on some scanners) before the actual CT angiogram is necessary in patients with cardiac dysfunction, since with lower cardiac output, contrast will take longer to opacify the arteries [89, 90] .
• Evaluation of the peripheral arteries and minimization of motion is obtained when slice thickness is lower. A thickness of 3 mm is ideal (5 mm maximum), and reconstruction to 1 or 1.5 mm thickness is helpful [73] . • The scan should encompass the top of the diaphragm to the top of the aortic arch covering a field of view from inner rib to inner rib in a caudal to cranial direction while the patient suspends respiration (if possible). Furthermore, scanning caudal to cranial improves contrast between the lower-lobe arteries and veins where most emboli are found [5, 83, [91] [92] [93] .
• Incomplete opacification of vessels due to poor contrast flow rate, insufficient flow or poor timing, confusing veins for arteries, mucoid impaction in a bronchus and hilar lymph nodes may mimic emboli [94] .
• In ventilated patients, ventilation should be suspended at high lung volumes to increase pulmonary resistance and therefore increase vascular opacification [95] . • The radiation dose from CT angiography is lower than invasive angiography and can be lowered further with thin collimation and high pitch [65] .
TECHNICAL DETAILS: CATHETER ANGIOGRAPHY
• For invasive/catheter pulmonary angiography, the unit must be capable of producing subtracted images.
• All patients undergoing pulmonary angiography via a femoral vein approach should have pre-procedure lower extremity ultrasound to exclude thrombosis.
• Additional cardiac monitoring is required during the procedure due to some patients developing transient RBBB or cardiac arrhythmia. The primary operator cannot monitor the patient during the procedure. Another medical professional should be available to monitor ECG strip.
• DSA improves the image quality, and careful monitoring reduces life threatening complication by early identification of rhythm abnormalities induced by catheter manipulation within the heart [52, 76, 77] .
• If the femoral veins are thrombosed, attempted vascular access for catheter angiography may be difficult or cause embolization of the thrombus.
CATHETER ANGIOGRAPHY-DIRECTED TREATMENT
Thrombolysis for sub-massive pulmonary embolism remains controversial. A recent multi-center trial compared heparin and alteplase with heparin and placebo in 256 patients [96] . Hospital stay, catecholamine use, and secondary thrombolysis were higher in the heparin and placebo group, and mortality was not statistically significant. Unfortunately, this study is limited by poor design of use of heparin (5,000 U bolus) and then 1,000 U/hr in both arms. Standard heparin dosing is a 80 U/kg bolus and 18 U/kg/hr. It is clear the patients in the heparin arm were being under-dosed (males average weight = 86.7 kg [+/-16.0] and females average weight = 75.6 kg [+/-13.6]). Outcome may have been improved in these patients had they received adequate initial anticoagulation. Furthermore the use of lower levels of heparin may explain why there was less intracranial hemorrhage than in prior trials, further biasing the trial.
PATIENT CONSENT ISSUES
Angiography often requires the patient to sign informed consent. There are slight but real risks associated with the procedure.
• In a large-scale series of 547 patients evaluating the safety of pulmonary angiography, two patients had reversible arrhythmias as a result of the catheter passage through the right side of the heart, as well as sideeffects to sedatives in two patients. The overall adverse reaction rate was 4.8 percent without any procedureattributable deaths [54] . In a series evaluating out patient diagnostic angiography (that did not include pulmonary angiography), up to 8.6 percent of patients undergoing diagnostic angiography experience self-limiting local pain at the catheter insertion site [97] . The greatest risk to a contrast reaction is a previous contrast reaction [29] . The risk of all adverse drug reactions with non-ionic contrast administration in the general population is between 1.2 percent and 3.13 percent [28, 38] . Risks relate to contrast administration for all types of angiography.
• [98] . In other series, as many as 10 percent experience systemic reactions (including abdominal cramps, slight fever, nausea) but these are invariably self limiting [46, 53] .
POST PROCEDURE AND FOLLOW-UP
• In the general population (without risk factors to contrast administration), contrast reactions requiring medical therapy are rare [28, 38] . Adverse drug reactions will almost always manifest within 24 hours, the majority of which manifest while the patient is still in the radiology suite [23, 28, 32, 33, 41, 42, 46] . Minor drug reactions need not be followed up unless complications arise.
• Patients with type II diabetes on Metformin should not resume Metformin after contrast administration until a 48-hour renal function has been checked [43, 46] . • Patients should drink copious amounts of fluid unless a contraindication to excessive hydration exists. Hydration (unless contra-indicated) is the best proven intervention that reduces renal toxicity [53] .
• Patients with pre-existing diabetes or renal dysfunction will need to return to the referring physician for evaluation of renal function. Abnormal rises in serum creatinine should be evaluated, and the patient should be treated or followed until creatinine returns to pre procedure baseline [23, 33] .
• Patients undergoing angiography may experience injection site pain and bruising, as well as minor systemic symptoms. These are self limiting.
• Patients undergoing invasive angiography should be at bed rest for six hours and have reduced activity for 24 hours. In a series evaluating outpatient diagnostic angiography (that did not include pulmonary angiography), up to 25 percent of patients undergoing diagnostic angiography experience self limiting pain and/or bruising. Yet only 1.5 percent experienced a medically significant adverse effect (such as renal deterioration, contrast allergy, etc.) [97] . The higher rate of pain and bruising can be attributed to the increased mobility of outpatients post procedure and emphasizes the need for patients to have reduced activity for at least 6 hours post invasive angiography.
• Breast feeding mothers should avoid breast feeding for 24 hours as iodinated contrast is excreted in breast milk and may cause transient neonatal hypothyroidism.
CONCLUSION
This paper provides a framework to guide clinicians through the process of evaluating for the presence of pulmonary emboli and provides a decision tree for potential situations (Figure 1) . CT pulmonary angiography has been shown to be a safe and effective modality for the evaluation of the pulmonary vasculature. 
